Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

11.5%

3 terminated/withdrawn out of 26 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

N/A
16(69.6%)
Phase 2
6(26.1%)
Phase 4
1(4.3%)
23Total
N/A(16)
Phase 2(6)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT07492472Not ApplicableRecruiting

The Effects of Low-Intensity Music in Adolescents With Anxiety

Role: lead

NCT07480317Not ApplicableNot Yet Recruiting

TIS for Brain Network Modulation and Clinical Efficacy in Parkinson's Disease

Role: lead

NCT07317557Not ApplicableNot Yet Recruiting

Remote Ischemic Conditioning for Cognitive Impairment in Cerebral Small Vessel Disease

Role: lead

NCT07323121Not ApplicableNot Yet Recruiting

40 Hz Flickering for Insomnia in Parkinson's Disease

Role: lead

NCT07299240Not ApplicableNot Yet Recruiting

Remote Ischemic Conditioning for Sleep Disturbances and Other Non-motor Symptoms in Parkinson's Disease

Role: lead

NCT07247344Recruiting

Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study

Role: lead

NCT05850598Not ApplicableCompleted

Effect of rTMS of the Cerebellum on Parkinson's Disease

Role: lead

NCT07246044Not ApplicableRecruiting

HD-tDCS for Adolescent Bipolar Depression Targeting S1

Role: lead

NCT07075237Phase 4Not Yet Recruiting

Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia

Role: lead

NCT05465928Not ApplicableCompleted

Personalized Repetitive Transcranial Magnetic Stimulation Treatment for Major Depressive Episode

Role: lead

NCT06766591Not ApplicableNot Yet Recruiting

Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs

Role: lead

NCT05611372Phase 2Withdrawn

Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease

Role: collaborator

NCT04152655Phase 2Withdrawn

A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease

Role: collaborator

NCT06332300Phase 2Withdrawn

An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC

Role: lead

NCT06270433Not ApplicableRecruiting

Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder

Role: lead

NCT06339242Phase 2Recruiting

A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis

Role: lead

NCT06332287Phase 2Recruiting

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis

Role: lead

NCT06315686Phase 2Recruiting

The Dynamic Monitoring of Cerebrospinal Fluid ctDNA

Role: lead

NCT06238869Not ApplicableUnknown

Online Mental Health Interventions for Children and Adolescents (OMHICA)

Role: lead

NCT05498441Not ApplicableUnknown

Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive Episode

Role: lead